A Study to Assess the Bioequivalence of Fixed Dose Combination (FDC) Tablets of Canagliflozin and Metformin Immediate Release (IR) With Respect to the Individual Components of Canagliflozin and Metformin IR Tablets in Healthy Volunteers
Clinical trial NCT01463228 · COMPLETED
Trial details
- NCT number
- NCT01463228
- Sponsor
- Janssen Research & Development, LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2011-09-01
- Primary completion
- 2012-01-01
- Enrollment
- 83
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.